BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jain A, Lamperti M, Doyle DJ. Dexmedetomidine: another arrow in the quiver to fight COVID-19 in intensive care units. Br J Anaesth 2021;126:e35-8. [PMID: 33190859 DOI: 10.1016/j.bja.2020.10.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Layton R, Layton D, Beggs D, Fisher A, Mansell P, Stanger KJ. The impact of stress and anesthesia on animal models of infectious disease. Front Vet Sci 2023;10. [DOI: 10.3389/fvets.2023.1086003] [Reference Citation Analysis]
2 Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Habotta OA, Batiha GE. High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons. Inflammopharmacology 2022. [PMID: 35471628 DOI: 10.1007/s10787-022-00988-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
3 Hamilton JL, Vashi M, Kishen EB, Fogg LF, Wimmer MA, Balk RA. The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19. Front Med (Lausanne) 2021;8:797647. [PMID: 35059419 DOI: 10.3389/fmed.2021.797647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sharma V, Sarwar M, Koleini E. Post-operative Non-sustained Ventricular Tachycardia in a COVID-19 Positive Patient After Ketamine and Dexmedetomidine Infusion. Cureus 2021. [DOI: 10.7759/cureus.20300] [Reference Citation Analysis]
5 Corriden R, Schmidt BE, Olson J, Okerblom J, Masso-Silva JA, Nizet V, Meier A. Dexmedetomidine does not directly inhibit neutrophil extracellular trap production. Br J Anaesth 2021:S0007-0912(21)00742-X. [PMID: 34916052 DOI: 10.1016/j.bja.2021.11.015] [Reference Citation Analysis]
6 Uusalo P, Valtonen M, Järvisalo MJ. Hemodynamic and respiratory effects of dexmedetomidine sedation in critically ill Covid-19 patients: A retrospective cohort study. Acta Anaesthesiol Scand 2021;65:1447-56. [PMID: 34368946 DOI: 10.1111/aas.13970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Jain A, Lamperti M, Doyle DJ, Lobo FA. Anaesthesia drugs, SARS-CoV-2, and the sigma-1 receptor: a complex affair. Comment on Br J Anaesth 2021; 127: e32-4. Br J Anaesth 2021;127:e215-8. [PMID: 34635287 DOI: 10.1016/j.bja.2021.09.008] [Reference Citation Analysis]
8 Keswani M, Mehta N, Mazer-Amirshahi M, Tran QK, Pourmand A. Sedation in mechanically ventilated covid-19 patients: A narrative review for emergency medicine providers. Am J Emerg Med 2021:S0735-6757(21)00413-7. [PMID: 34020844 DOI: 10.1016/j.ajem.2021.05.030] [Reference Citation Analysis]
9 Hirota K, Lambert DG. Anaesthesia-related drugs and SARS-CoV-2 infection. Br J Anaesth 2021;127:e32-4. [PMID: 33934887 DOI: 10.1016/j.bja.2021.03.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Taboada M, Baluja A, Santos LD, González I, Veiras S, Caruezo V, Naveira A, Mirón P, Novoa C, Doldán P, Calvo A, Tubio A, Selas S, Eiras M, Martínez A, Campaña O, Rodríguez MT, Diaz-Vieito M, Cariñena A, Otero P, Mariño G, Domínguez M, Muniategui I, Aneiros F, Alvarez J. Effectiveness of dexmedetomidine combined with high flow nasal oxygen and long periods of awake prone positioning in moderate or severe COVID-19 pneumonia. J Clin Anesth 2021;72:110261. [PMID: 33839432 DOI: 10.1016/j.jclinane.2021.110261] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]